oasis 1 oral semaglutide 50 mg obesity nejm 2023 Oral Semaglutide 25 mg and Orforglipron for Obesity: New NEJM Insights ๐ฅผ๐งชSlide Deck: Efficacy and safety
Description
79 Although liver biopsy is considered as the gold standard, its acceptance rate is relatively low due to various limitations
GIP contributes to improving insulin sensitivity in adipose tissue, reducing ectopic fat accumulation, and optimizing lipid profiles
Before choosing any GLP-1 provider, confirm your clinical history with the prescribing clinician and establish a plan for ongoing monitoring
Switching from injectable tirzepatide
01185-6/asset/4a8b6ac7-0944-49bb-a528-111e459b6c4e/main.assets/gr1.jpg)
However, its essential to note that these responses can be highly individualized, with some patients tolerating higher doses without significant reflux issues
